AVDL
Avadel Pharmaceuticals
AVDL
AVDL
Delisted
AVDL was delisted on the 11th of February, 2026.
204 hedge funds and large institutions have $1.59B invested in Avadel Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 68 funds opening new positions, 44 increasing their positions, 72 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
10% more funds holding
Funds holding: 186 → 204 (+18)
6.83% less ownership
Funds ownership: 82.14% → 75.31% (-6.8%)
39% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 72
Holders
204
Holding in Top 10
9
Calls
$100M
Puts
$45.3M
Top Buyers
| 1 | +$87.7M | |
| 2 | +$74.9M | |
| 3 | +$57.1M | |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
+$54.8M |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$39.8M |
Top Sellers
| 1 | -$109M | |
| 2 | -$101M | |
| 3 | -$82M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$61.1M |
| 5 |
Morgan Stanley
New York
|
-$33.6M |
